ACI Formulations (DHA:ACIFORMULA) Other Current Payables: BDT862 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ACIFORMULA ACI Formulations PLC DHA:ACIFORMULA
91 GF Score
Price BDT152.70
GF Value BDT150.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is ACI Formulations Other Current Payables?

ACI Formulations DHA:ACIFORMULA +3.11% 91 Other Current Payables is BDT862 Mil as of Mar. 2026. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 91/100 and a GF Value™ of BDT150.73 (Fairly Valued). The stock has 4 warning signs investors should review.

ACI Formulations's Other Current Payables for the quarter that ended in Mar. 2026 was BDT862 Mil.

ACI Formulations's quarterly Other Current Payables increased from Sep. 2025 (BDT606 Mil) to Dec. 2025 (BDT870 Mil) but then declined from Dec. 2025 (BDT870 Mil) to Mar. 2026 (BDT862 Mil).

ACI Formulations's annual Other Current Payables increased from Jun. 2023 (BDT456 Mil) to Jun. 2024 (BDT487 Mil) and increased from Jun. 2024 (BDT487 Mil) to Jun. 2025 (BDT589 Mil).

ACI Formulations Other Current Payables Related Terms

ACI Formulations Other Current Payables Historical Data

* Premium members only.

The historical data trend for ACI Formulations's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACI Formulations Other Current Payables Chart

ACI Formulations Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 729.34 437.14 455.56 487.49 589.41

ACI Formulations Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 636.97 589.41 606.14 870.50 862.25
DHA:ACIFORMULA
91GF Score
ACI Formulations PLC DHA:ACIFORMULA
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACI Formulations Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of BDT862 Mil mean?
ACI Formulations (DHA:ACIFORMULA) has a Other Current Payables of BDT862 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' Other Current Payables too high?
ACI Formulations' current Other Current Payables is BDT862 Mil. Overall, ACI Formulations has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Other Current Payables compare to CTVA and CF?
ACI Formulations' Other Current Payables of BDT862 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for an Agriculture company?
A good Other Current Payables depends on the Agriculture industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on ACI Formulations and its competitors. ACI Formulations's current Other Current Payables is BDT862 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Fairly Valued. The stock's GF Value™ is BDT150.73, compared to a current price of BDT152.70 — trading 1.3% above its estimated fair value. The current Other Current Payables is BDT862 Mil. ACI Formulations' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Other Current Payables is BDT862 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?

Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued. The current stock price of BDT152.70 is trading 1.3% above its estimated GF Value™ of BDT150.73. GuruFocus considers ACI Formulations to be Fairly Valued.

Key valuation signals for DHA:ACIFORMULA:

  • Other Current Payables: BDT862 Mil
  • GF Value™: BDT150.73 vs. price of BDT152.70 (1.3% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACI Formulations Business Description

Address ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
91GF Score

Get the complete analysis for DHA:ACIFORMULA

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT152.70
Price
BDT150.73
GF Value